Aberdeen Group’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.32M Buy
90,124
+15,000
+20% +$1.51M 0.01% 619
2025
Q4
$7.67M Sell
75,124
-40,577
-35% -$3.63M 0.01% 652
2025
Q3
$7.23M Sell
115,701
-57,560
-33% -$3.13M 0.01% 655
2025
Q2
$9.02M Sell
173,261
-79,702
-32% -$3.56M 0.02% 619
2025
Q1
$10.8M Sell
252,963
-189,988
-43% -$8.2M 0.02% 546
2024
Q4
$13.5M Sell
442,951
-109,522
-20% -$3.08M 0.03% 448
2024
Q3
$12.7M Buy
552,473
+178,882
+48% +$5.06M 0.02% 470
2024
Q2
$10.8M Sell
373,591
-84,200
-18% -$1.96M 0.02% 499
2024
Q1
$9.44M Buy
457,791
+111,707
+32% +$2.39M 0.02% 561
2023
Q4
$9.36M Buy
+346,084
New +$9.08M 0.02% 562

Other funds holding GH